| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/08/1997 | EP0751789A1 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/08/1997 | EP0751778A1 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same |
| 01/08/1997 | EP0751777A1 USE OF GINSENOSIDE R o? OR A PLANT EXTRACT CONTAINING SAME TO PROMOTE COLLAGEN SYNTHESIS |
| 01/08/1997 | EP0751776A1 Novel pharmaceutical composition for skin diseases |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | CN1139571A Ointment for burns made of Saussurea Involucrata |
| 01/08/1997 | CN1139559A Adhesive plaster for wound |
| 01/07/1997 | US5591450 L-carnitine salt and compositions containing same |
| 01/07/1997 | US5591444 Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 01/07/1997 | US5591437 Cosmetic or pharmeceutical composition containing a black horehound extract |
| 01/07/1997 | CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/03/1997 | WO1997000242A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 01/03/1997 | WO1997000075A1 Ameliorant for pruritus cutaneous accompanying renal failure |
| 01/03/1997 | WO1996037201A3 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/03/1997 | WO1996030009A3 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid |
| 01/03/1997 | CA2224660A1 A pharmaceutical agent for the treatment of pruritus cutaneus associated with renal failure |
| 01/03/1997 | CA2224440A1 New vitamin d derivatives with substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 01/02/1997 | EP0751217A2 Enhancing keratinocyte migration with clostridiopeptidase-A-collagenase |
| 01/02/1997 | EP0751137A1 Oxaindene derivatives and a process for preparing them as well as medicaments containing them and the use of them |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750604A1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
| 01/02/1997 | EP0750515A1 Low molecular weight hyaluronic acid with peptide or protein |
| 01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 01/02/1997 | EP0750510A1 Skin treatment composition |
| 01/02/1997 | EP0750498A1 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 01/01/1997 | CN1139383A Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139105A Stable microemulsions of certain 3-isothiazolone compounds |
| 12/31/1996 | US5589508 Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases |
| 12/31/1996 | US5589497 Antiandrogens |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589179 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it |
| 12/31/1996 | US5589178 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof |
| 12/30/1996 | CA2177558A1 Cellulose ester wound dressing |
| 12/28/1996 | CA2180029A1 Oxaindene derivatives and process for the preparation thereof |
| 12/27/1996 | WO1996041818A1 Chitin hydrogels, methods of their production and use |
| 12/27/1996 | EP0749753A2 Use of a powder or an extract of guava for treating allergic diseases |
| 12/27/1996 | EP0749752A1 Use of specific RXR receptor ligands |
| 12/27/1996 | EP0749428A1 Isoxazoline compounds as inhibitors of tnf release |
| 12/27/1996 | EP0749310A1 New use of quinoline-3-carboxamide compounds |
| 12/27/1996 | EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 12/27/1996 | CA2224253A1 Chitin hydrogels, methods of their production and use |
| 12/25/1996 | CN1138865A Peptides and methods against psoriasis |
| 12/25/1996 | CN1138851A Metalloproteinase inhibitors |
| 12/25/1996 | CN1138477A Chinese medicinal preparation for treatment skin disease and its prepn. method |
| 12/25/1996 | CN1138457A Medicine for treatment of psoriasis |
| 12/24/1996 | US5587497 19-nor-vitamin D compounds |
| 12/24/1996 | US5587367 Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 12/24/1996 | US5587176 Methods of using hesperetin for sebum control and treatment of acne |
| 12/24/1996 | US5587174 Cosmetic composition for treating skin and hair containing apple wax and methods of making them |
| 12/24/1996 | US5587171 Synergistic oxidation resistant mixture |
| 12/24/1996 | US5587169 Cosmetic or pharmaceutical composition comprising an alkyl carbamate as hydrating agent |
| 12/20/1996 | CA2179426A1 Use of ligands specific to rxr receptors |
| 12/19/1996 | WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
| 12/19/1996 | WO1996040705A1 C-4' modified adenosine kinase inhibitors |
| 12/19/1996 | WO1996040672A1 Combinatorial libraries having aminodiol monomer subunits |
| 12/19/1996 | WO1996040636A1 Catechol diethers derivatives useful as pharmaceutical agents |
| 12/19/1996 | WO1996040232A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation |
| 12/19/1996 | WO1996040174A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 12/19/1996 | WO1996040166A1 Nucleotide analogues for topical treatment of proliferative disease of the skin |
| 12/19/1996 | WO1996040160A1 Use of pseudopterosins for promoting wound healing |
| 12/19/1996 | WO1996040154A1 Use of vitamin d4 derivatives for treating skin disorders |
| 12/19/1996 | WO1996040143A1 Imidazole compounds |
| 12/19/1996 | WO1996040142A1 Heterocyclic ring-fused pyrimidine derivatives |
| 12/19/1996 | WO1996040116A1 Indolinone compounds for the treatment of disease |
| 12/19/1996 | WO1996040110A1 Novel benzopyran compounds and methods for their use |
| 12/19/1996 | WO1996040104A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds |
| 12/19/1996 | WO1996040048A2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 12/19/1996 | WO1996036222A3 Improved method for controlling ectoparasites |
| 12/19/1996 | CA2224100A1 Novel benzopyran compounds and methods for their use |
| 12/19/1996 | CA2223889A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 12/19/1996 | CA2223533A1 Imidazole compounds |
| 12/19/1996 | CA2223462A1 Use of pseudopterosins for promoting wound healing |
| 12/19/1996 | CA2222591A1 Use of vitamin d4 derivatives for treating skin disorders |
| 12/19/1996 | CA2222224A1 Nucleotide analogues for topical treatment of proliferative disease of the skin |
| 12/19/1996 | CA2220642A1 C-4' modified adenosine kinase inhibitors |
| 12/19/1996 | CA2219457A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation |
| 12/18/1996 | EP0748633A2 Adhesive tissue and its use as haemostyptic |
| 12/18/1996 | EP0748317A1 Novel thiazolidin-4-one derivatives |
| 12/18/1996 | EP0748313A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives |
| 12/18/1996 | EP0748312A1 Bicyclic carbamates as leukotriene d4 antagonists |
| 12/18/1996 | EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 12/18/1996 | EP0748215A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 12/18/1996 | CN1138336A Cationic biopolymers |
| 12/18/1996 | CN1138294A Psoriasis treatment |
| 12/18/1996 | CN1137919A Medicine for curing trichomadesis and its preparation method |
| 12/18/1996 | CN1137916A Medicine for treating burn and scald and its preparation method |
| 12/18/1996 | CN1137913A Brightening and spot-removing face-beautifying preparation and its preparation method |
| 12/18/1996 | CN1137912A Tongyangqing for curing pain and itch |
| 12/18/1996 | CN1137911A Cuochuangjing face cream for curing acne |
| 12/17/1996 | US5585492 LTA4 Hydrolase inhibitors |
| 12/17/1996 | US5585386 Mixtures for application to skin or scalp |
| 12/17/1996 | US5585368 Skin disorders |
| 12/17/1996 | US5585109 Cosmetic delivery system for salicylic acid and process for preparation of same |
| 12/13/1996 | CA2178789A1 Hemostyptic and tissue adhesive |
| 12/12/1996 | WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 12/12/1996 | WO1996039515A1 Human vascular endothelial growth factor 2 |
| 12/12/1996 | WO1996039507A1 Fibroblast growth factor 11 |
| 12/12/1996 | WO1996039497A1 Transforming growth factor alpha hi |
| 12/12/1996 | WO1996039415A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |